Transaction #1512 · Form 5 · 0000912282-25-001096
AYTU BIOPHARMA, INC · Purchase · Common Shares
AYTU BIOPHARMA, INC · Transacted November 18, 2020 · Filed October 20, 2025
What does this filing report?
An SEC Form 5 filing for AYTU BIOPHARMA, INC records a purchase involving Common Shares on November 18, 2020. The reported quantity was 10,000. The filing date is October 20, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- AYTU BIOPHARMA, INC
- Company CIK
- 0001385818
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 10,000
- Reported price
- 0.923
- Reference value
- 9,230
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 50
- Ownership description
- Alpha Venture Capital Management, LLC
- SEC acceptance time
- Oct 20, 2025, 3:56 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- DOCKERY CARL ↗
Director
CIK 0001618149
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The Reporting Person's purchase and sale of AYTU common shares (the "Shares") reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 209 Shares sold on December 30, 2020, with the Reporting Person's purchase of 10,000 Shares on November 18, 2020. After taking into consideration the Issuer's 10:1 reverse stock split on December 10, 2020, the price for the November 18, 2020, purchase was $9.23 per share, or a total purchase price of $1,929.07 for 209 Shares. The total sale price of 209 Shares on December 30, 2020, was $1,256.09. THE REPORTING PERSON DID NOT REALIZE ANY PROFIT IN CONNECTION WITH THE SHORT-SWING PURCHASE AND SALE.
- F2
- Represents total Shares held following stock splits on June 30, 2016 (12:1), August 25, 2017 (20:1), August 13, 2018 (20:1), December 10, 2020 (10:1) and January 6, 2023 (20:1).
- F3
- Includes 10,000 restricted shares granted to the Reporting Person on October 3, 2025, and reported on a Form 4 filed with the Securities and Exchange Commission on October 7, 2025.
Remarks
The total direct shares reported above in Table I, Column 5, include a correction to an error in the total number of securities reported in Column 5 of Table I on the Form 4 filed with the Securities and Exchange Commission on April 16, 2021.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.